Edaravone, sold under the brand name Radicava among others, is a medication used to treat stroke and amyotrophic lateral sclerosis (ALS). It is administered by intravenous infusion and is also available in an oral formulation. Although the exact mechanism by which Edaravone might be effective is unknown, it is thought to act as a free radical scavenger, potentially reducing oxidative stress associated with ALS progression. Edaravone has been shown to slow functional decline in ALS patients, making it an important therapeutic option in managing this neurodegenerative disease.
Parent: Edaravone
Parent: Edaravone
Parent: Edaravone
![5,5''-dihydroxy-3,3'',5'-trimethyl-1,1'',2'-triphenyl-4,4'',5,5''-tetrahydro-1H,1''H-[4,4':4',4''-terpyrazol]-3'(2'H)-one](https://veeprho.com/wp-content/uploads/2024/04/VE0019760-5-5-dihydroxy-3-3-5-trimethyl-1-1-2-triphenyl-4-4-5-5-tetrahydro-1H-1-H-4-4-4-4-terpyrazol-3-2-H-one.png "5,5''-dihydroxy-3,3'',5'-trimethyl-1,1'',2'-triphenyl-4,4'',5,5''-tetrahydro-1H,1''H-[4,4':4',4''-terpyrazol]-3'(2'H)-one")
Parent: Edaravone
During the production and storage of Edaravone, impurities may form, which must be carefully controlled to ensure the drug’s safety and efficacy. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) set guidelines on acceptable impurity levels in Edaravone formulations.
Edaravone may slow the progression of ALS and extend life expectancy to some degree, although the exact duration varies between individuals. Clinical studies suggest that Edaravone helps reduce functional decline in ALS patients, potentially improving quality of life and delaying disease progression when used alongside other treatments.
Edaravone is contraindicated in patients with a history of hypersensitivity to the drug or its components, as allergic reactions can occur. Additionally, caution is advised in patients with renal impairment, as Edaravone is primarily excreted by the kidneys.
Edaravone targets oxidative stress by scavenging free radicals in the body. This action helps reduce cellular damage, which is thought to play a role in the progression of ALS and certain other neurodegenerative conditions.
Edaravone is sensitive to light and should be stored in its original packaging to maintain stability. It is also susceptible to degradation when exposed to high temperatures or humidity, so it should be stored at controlled room temperature and protected from light to ensure optimal potency.
